Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Hurotics

Explore full profile

Wearable robotics for rehabilitation and athletic performance

Seoul, South KoreaFounded 2022Health Tech & Medtech
Valuation $0–100M Latest valuation · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Hurotics and the history behind them.

About Hurotics

Hurotics Inc., established in 2021 by Sang-goke Jung, Chan and Sang-Rok Oh, develops wearable robotic technology focused on the wellness and sports sectors. The company aims to enhance everyday life through products designed for both rehabilitation and the elevation of athletic performance. The founding team brings together expertise from diverse fields; Sang-goke Jung holds a Ph.D. in Mechanical Engineering from KAIST and has experience at the Korea Institute of Industrial Technology, while Sang-Rok Oh is a professor at KAIST's Department of Mechanical Engineering with a Ph.D. from the same institution. Chan has a background in industrial design from KAIST.

Read full description

The company's core technology revolves around a proprietary high-power, lightweight actuator, which is a key component in their wearable robots. This allows for the creation of devices that are both powerful and comfortable for the user. One of their flagship products is the 'H-Flex' series, specifically the H-Flex leg, a soft wearable robot designed to assist with walking and lower body muscle strength. This product is targeted at individuals needing walking assistance due to muscle strength decline, such as the elderly or those in post-surgery rehabilitation. Hurotics has secured significant funding to support its growth, including a pre-Series A investment and a KRW 2 billion seed investment from investors like Naver D2SF and Z Venture Capital.

Hurotics operates in the growing market of wearable robotics, targeting both the healthcare and sports industries. Its business model likely involves the direct sale of its robotic devices to individuals, rehabilitation centers, and sports organizations. The company has gained recognition through various awards, including the CES 2024 Innovation Award, and by being selected for programs like the 'be global BIG B.A.N.G' and the Chung Mong-Koo Foundation's 'H-OnDream Startup' program, which supports promising startups. Keywords: wearable robotics, rehabilitation technology, athletic performance, assistive technology, exoskeletons, wellness technology, sports robotics, actuator technology, physical therapy, mobility assistance

Source: Dealroom company data

At a glance

Founded
2022
Headquarters
Seoul, South Korea
Sector
Health Tech & Medtech

Latest news

Press, funding announcements and product moves mentioning Hurotics.

See all news

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • Aju IB Investment
  • WONIK Investment Partners
  • Korea Credit Guarantee Fund
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇰🇷 South Korea100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Hurotics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hurotics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.